A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

NCT00002314 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Ro 24-7429

Sponsor

Hoffmann-La Roche